Similar Papers

Paper Title
Journal
Date
Author
Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future
T Robinson ... J.P Braybrooke
Clinical Oncology | VOL. 32
T Robinson, et. al.T Robinson ... J.P Braybrooke
14 May 2020
Abstract P4-21-34: Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
...
Cancer Research | VOL. 77
, et. al. ...
14 Feb 2017
Abstract OT-34-01: Phase Ib/II trial of copanlisib in combination with trastuzumab and pertuzumab after induction treatment of HER2 positive metastatic breast cancer with PIK3CA mutation or PTEN mutation
Senthil Damodaran ... Debu Tripathy
Cancer Research | VOL. 81
Senthil Damodaran, et. al.Senthil Damodaran ... Debu Tripathy
15 Feb 2021
Clinical value of trastuzumab in the treatment of lapatinib-resistant HER2-positive metastatic breast cancer
Bing-He Xu ... Hui-Hui Li
Chinese journal of oncology | VOL. 35
Bing-He Xu, et. al.Bing-He Xu ... Hui-Hui Li
01 Jul 2013
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
Updated results from the phase Ib/II study of fruquintinib combined with SOX and toripalimab in patients with advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC).
Xiangrui Meng ... Lulu Guan
Journal of Clinical Oncology | VOL. 43
Xiangrui Meng, et. al.Xiangrui Meng ... Lulu Guan
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.